The groundbreaking success of Viagra, produced by copyright, undeniably transformed the management of erectile dysfunctionality, and fueled a massive surge in the pharmaceutical sector. However, now, investing in corporations reliant on established blockbuster drugs like Viagra presents a complex landscape. Generic competition is aggressive, consid